Engineers Gate Manager LP Cara Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.65 $18,444 - $50,721	30,740 New	30,740 $22,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $41,074 - $71,699	14,514 New	14,514 $41,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $130,375 - $242,200	17,500 New	17,500 $160,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $210,568 - $267,977	-21,184 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $194,190 - $293,795	-16,196 Reduced 43.33%	21,184 $258,000
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $431,739 - $600,322	37,380 New	37,380 $578,000
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $141,751 - $334,225	-11,450 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$15.07 - $21.71 $239,311 - $344,754	-15,880 Reduced 58.1%	11,450 $249,000
Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $8,776 - $11,150	690 Added 2.59%	27,330 $414,000
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $181,311 - $263,298	14,693 Added 122.98%	26,640 $339,000
Q2 2020 Aug 17, 2020	BUY	$12.39 - $17.33 $148,023 - $207,041	11,947 New	11,947 $204,000
Q4 2019 Feb 14, 2020	SELL	$16.11 - $25.98 $164,676 - $265,567	-10,222 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $186,858 - $275,074	10,222 New	10,222 $187,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $257M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.